BCAX
Bicara Therapeutics

78
Loading...
Loading...
News
all
press releases
Bicara Therapeutics Inc. (NASDAQ:BCAX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eleven analysts that are currently covering the company, MarketBeat...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) CFO Sells 1,882 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CFO Ivan Hyep sold 1,882 shares of the company's stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an...
MarketBeat·10d ago
News Placeholder
Ryan Cohlhepp Sells 3,828 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) COO Ryan Cohlhepp sold 3,828 shares of the business's stock in a transaction dated Thursday, January 22nd. The stock was sold at an average...
MarketBeat·10d ago
News Placeholder
Wedbush Reaffirms Outperform Rating for Bicara Therapeutics (NASDAQ:BCAX)
Wedbush reiterated an "outperform" rating and issued a $30.00 target price on shares of Bicara Therapeutics in a research note on Tuesday...
MarketBeat·23d ago
News Placeholder
Bicara Therapeutics Touts Breakthrough Ficerafusp Data, Picks 1,500 mg Dose for FORTIFY-HNS Trial
Bicara Therapeutics (NASDAQ:BCAX) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its 2026 corporate outlook and highlight 2025 milestones centered on its lead...
MarketBeat·23d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Shares Down 7% - Time to Sell?
Bicara Therapeutics (NASDAQ:BCAX) Trading Down 7% - What's Next...
MarketBeat·24d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Trading Up 7.8% - Here's Why
Bicara Therapeutics (NASDAQ:BCAX) Shares Up 7.8% - Here's What Happened...
MarketBeat·27d ago
News Placeholder
Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives Consensus Rating of "Hold" from Analysts
Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) have been given an average rating of "Hold" by the seven ratings firms that are presently covering the company, Marketbeat Ratings...
MarketBeat·1mo ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Stock Price Up 3.9% - Still a Buy?
Bicara Therapeutics (NASDAQ:BCAX) Trading 3.9% Higher - Here's Why...
MarketBeat·1mo ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Raised to "Hold" at Mizuho
Mizuho upgraded shares of Bicara Therapeutics to a "hold" rating in a research report on Thursday...
MarketBeat·2mo ago
<
1
2
...
>

Latest BCAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.